
Glaucoma Doctors Answer Frequently Asked Questions
Leading ophthalmologists answer questions about traumatic glaucoma, natural childbirth and glaucoma, how vision loss is measured, and why there are so many glaucoma exams.
Leading ophthalmologists answer questions about traumatic glaucoma, natural childbirth and glaucoma, how vision loss is measured, and why there are so many glaucoma exams.
Leading specialists answer questions about medication side effects, whether working at a computer makes glaucoma worse, “glaucoma suspects,” and more.
Glaucoma specialists answer questions about medications and surgery, diet and exercise, marijuana and other alternative treatments, correlations with other chronic health conditions, and more.
A glaucoma specialist answers questions about what to expect on your next eye doctor visit during the coronavirus pandemic.
Childhood glaucoma occurs in one out of every 10,000 births in the United States. In most cases, childhood glaucoma is diagnosed by the age of six months, with 80% diagnosed in the first year of life.
In this “Questions and Answers” article, learn about new glaucoma medications available in 2019, how they’re different from existing treatments, and their potential side effects.
Stem cell therapies are getting headlines for their potential to cure diseases, including those that affect vision. But an important message is missing: stem cell therapies are not yet proven to be safe and effective for your eyes.
In normal-tension glaucoma, the optic nerve gets damaged even though the eye pressure is within a normal range.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
The Gleams Newsletter includes interviews, personal stories, and current information about glaucoma, new treatments, updates on research findings, and more. You can subscribe to the printed version of Gleams or the electronic version — both are free.
FOR EYECARE PROFESSIONALS
FOR EYECARE PROFESSIONALS
Glaucoma Research Foundation • 251 Post Street, Suite 600 • San Francisco, CA 94108 • 415-986-3162
Send us an email
We are a 501c3 tax-exempt national nonprofit. Our tax ID number is 94-2495035. Our EIN number is 94-2495035.
Copyright 2023 all rights reserved.
Print Subscription
We will mail Gleams anywhere in the United States and Canada, but we do not mail internationally. Please sign up for the email edition if you live outside of the US or Canada.
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.
E-mail Subscription
You can unsubscribe at any time. GRF will not share your personal information with any other organizations. Please see our Privacy Policy for further information.